Table of Contents
Molecular Biology International
Volume 2012, Article ID 701814, 8 pages
http://dx.doi.org/10.1155/2012/701814
Research Article

Combined RASSF1A and RASSF2A Promoter Methylation Analysis as Diagnostic Biomarker for Bladder Cancer

1Department of Radiation Oncology, The Ohio State University, Columbus, OH 43210, USA
2Department of Urology, The Ohio State University, Columbus, OH 43210, USA

Received 1 November 2011; Accepted 29 December 2011

Academic Editor: Farida Latif

Copyright © 2012 Wei Meng et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Wei Meng, Alexander Huebner, Ahmad Shabsigh, Arnab Chakravarti, and Tim Lautenschlaeger, “Combined RASSF1A and RASSF2A Promoter Methylation Analysis as Diagnostic Biomarker for Bladder Cancer,” Molecular Biology International, vol. 2012, Article ID 701814, 8 pages, 2012. https://doi.org/10.1155/2012/701814.